Scholars Central

ArticlePublished 20 Feb 2024

The Future of Targeted Therapy for Leiomyosarcoma: A Promising Horizon

Authors: Vlad Bratucu

Archives of Surgical Oncology

Volume 10 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Leiomyosarcoma (LMS), a malignant soft tissue tumor arising from smooth muscle cells, presents a significant therapeutic challenge due to its aggressive nature and limited treatment options. Conventional treatments such as surgery, chemotherapy, and radiation have shown limited efficacy, prompting the exploration of novel therapeutic strategies. Among these, targeted therapy has emerged as a promising approach, offering the potential to improve outcomes for patients with LMS. In this article, we delve into the current landscape of targeted therapy for LMS and explore the promising future directions in this field.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Archives of Surgical Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalArchives of Surgical Oncology
  • SubjectOncology & Cancer
  • SubjectSurgery
  • BylineArticles whose byline prints “Vlad Bratucu”